Background/Aims: Ketamine has been reported to exert anti-inflammatory effects on astrocytes stimulated by lipopolysaccharide (LPS) in vitro and in vivo. However, the mechanism has not been elicited clearly. The aim of this study was to investigate the effects of ketamine on TLR4 expression and NF-κB-p65 phosphorylation, as well as the production of proinflammatory cytokines in LPS challenged astrocytes. Methods: Astrocytes were stimulated with LPS (1µg/ ml) in the absence and presence of various concentrations of ketamine (10, 100, 1000µM). The concentrations of IL-1β, IL-6 and TNF-α were measured by ELISA, the expression of glial fibrillary acidic protein (GFAP) in astrocytes was detected by immunofluorescence staining, the level of phosphorylated NF-κB p65 and the expression of TLR4 were detected by western blotting. Results: LPS increased TLR4 expression and the phosphorylation of NF-κB p65 subunit as well as GFAP expression and the production of IL-1β, IL-6 and TNF-α in cultured astrocytes. Ketamine (100 and 1000 µM) reduced the expression of GFAP and the production of these proinflammatory cytokines, inhibited the expression of TLR4 and attenuated the phosphorylation of NF-κB p65 in astrocytes challenged by LPS. Conclusion: The inhibitory effects of ketamine on LPS-induced astrocytes activation and inflammation response may be mediated by suppressing NF-κB activation through reducing the expression of TLR4.
Introduction
In the central nervous system (CNS), the interaction among various cell types, neurons, astrocytes, microglia and oligodendrocytes, is important in the immune and in�lammatory responses. Among these cells, astrocytes are known to play a pivotal role in CNS immunity as immunocompetent cells by secreting cytokines and in�lammatory mediators [1, 2] . Activation of astrocytes leads to an in�lammatory response during disease, infection, trauma, and ischemia [3] , producing diverse proin�lammatory cytokines such as IL-1β, TNF-α and IL-6 [4] . A sustained in�lammatory response present in acute and chronic brain disorders may be a �irst step in the development of several neurodegenerative diseases [5, 6] . Therefore, the regulation of astrocyte in�lammatory response may be essential in pathological processes in the central nervous system.
Ketamine, an intravenous anesthesia inducing agent, has been showed anti-in�lammatory actions in various immune cells, such as macrophages and peripheral leucocytes, stimulated with lipopolysaccharide (LPS) in vitro and in vivo [7] [8] [9] . Recent in vitro and vivo studies demonstrated that ketamine inhibited astrocyte activation and blunted LPS-induced astrocyte TNF-alpha production [10] [11] [12] . However, the detailed mechanisms underlying the antiin�lammatory effects of ketamine in astrocytes stimulated by LPS have not been clearly revealed.
Toll-like receptor 4 (TLR4) is a member of the IL-1R/TLR superfamily that is required for LPS responsiveness and is involved in the host defense against Gram-negative bacteria [13] . According to recent �indings TLR4 is expressed in primary astrocytes, providing a mechanistic link between bacterial challenge and immune responses in the in�lammatory CNS disorders [14] . After ligand binding, TLRs/IL-1Rs dimerize and undergo the conformational change required for the recruitment of downstream signaling molecules and stimulation of downstream kinases, including activation of the transcriptional factors NF-κB [15] . The activation of NF-κB leads to the induction of genes encoding proin�lammatory cytokines such as IL-1β, IL-6 and TNF-α [16] .
The present study addressed the question whether ketamine could attenuate LPSinduced astrocyte in�lammatory response through inhibiting TLR4 expression and NF-κB activation, reducing proin�lammatory cytokines production in astrocyte. To this end, we investigated the effects of ketamine on LPS-induced production of IL-1β, IL-6 and TNF-α and relative mechanisms in primary cultures of rat astrocytes in vitro.
Materials and Methods
Primary culture of mixed glial cells Astrocytes were prepared from whole spinal cord of 1-day-old SD rats using the procedure described as the following literature [17] with some modifications. The meninges and blood vessels were carefully removed, and the tissue was minced with a mesh bag (200 µm) and trypsinized (trypsin-EDTA 2.5%) for 10 min. After centrifuging for 10 min at 1000 rpm, the tissues were resuspended in DMEM-F-12 containing FBS 10%, penicillin 100 U ml -1 and streptomycin 100 mg ml -1 . Cells were plated on 75 cm 2 culture flasks and kept in DMEM-F-12 supplemented with 10% FBS and the antibiotics in a humidi�ied 5% carbon dioxide atmosphere at 37°C. The medium was changed every 3 days after shaking the flasks to remove neuron and other glial cells.
Secondary culture of astrocytes
Mixed glials cultured for 12 or 13 days in 75 cm 2 flasks were shaken at 150 r.p.m. for 18h at 37°C on a gyratory shaker. The remaining source cultures were dissociated using trypsin and then collected by centrifuging (1000 r.p.m. for 5 min). The cells were seeded onto 24-well culture plates at 2×10 5 cells cm -2 and cultured for 24 h before being used as astrocytes.
Immuno�luorescence for GFAP
The astrocytes were fixed with 4% paraformaldehyde for 30 min and rinsed three times with PBS. Nonspecific binding was blocked with 10% Goat serum for 1h at room temperature. Subsequently, the astrocytes were incubated with glial �ibrillary acidic protein (GFAP) antibody (BOSTER) in the blocking buffer for 24 h at 4°C. After washing three times with PBS, the cells were incubated with the secondary antibody for 2 h at room temperature and rinsed. The preparations were mounted with glycerin and examined using an Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry inverted microscope equipped with �luorescence optics (OLYMPUS, Japan).
Treatment of astrocytes
Cells were divided into �ive groups treated with medium (control), LPS (1.0 µg ml
), different concentrations of ketamine (10, 100 and 1000 µM) and LPS (1.0 µg ml -1 ) respectively. Ketamine was administered 15 min before LPS treatment. After a 24 h LPS treatment, the cultured cells and supernatant were collected respectively. The supernatant was used to detect the level of proin�lammatory cytokines by ELISA. The collected cells were used to detect the expression of TLR4 and the activation of NF-κB by western blotting.
ELISA for IL-1β, IL-6 and TNF-α
IL-1β, IL-6 and TNF-α levels in supernatant were measured by enzyme-linked immunoadsorbent assay (ELISA) according to the protocols of the kits. Brie�ly, Cellfree supernatant was added to each well of a monoclonal rabbit anti-rat IL-1β (or IL-6, or TNF-α) antibody coated micro titre plates (ELISA plates) for 12 h at 4°C. Unbound material was washed off and a biotinylated monoclonal rabbit anti-rat IL-1β (or IL-6, or TNF-α) antibody was used for 45 min. Bound antibody was detected by addition of avidin-peroxidase for 30 min followed by incubation of the ABTS substrate solution. Absorbance was measured 20 min after addition of substrate. A standard curve was constructed using various dilutions of IL-1β (or IL-6, or TNF-α) standard preparation in the kit. The contents of IL-1β, IL-6 and TNF-α in the supernatant were determined by extrapolation of absorbance to the standard curve.
Western Blot Analysis for TLR4 and NF-κB
After drug treatment, cell lysates were prepared in ice-cold lysis buffer. Protein concentrations were quanti�ied using a bicinchonic acid protein assay kit (Beyotime). The protein sample (100µg/ well) was separated on a sodium dodecyl sulfate-polyacrylamide gel and electrophoretically transferred onto a nitrocellulose membrane in Tris-glycine transfer buffer. After blocking, TLR4, NF-κBp-65 and phosphorylation NF-κBp-65 (p-p-65) were immunodetected using different rabbit polyclonal antibodies. Cellular β-actin protein was immunodetected as the internal standard.
Statistics analysis
Data were presented as Mean±SD. SPSS-13.0 was used for data analysis. Differences among groups were determined by one way analysis of variance (ANOVA), followed by the Student-Newman-Keuls post hoc test. Signi�icance was de�ined as p<0.05.
Results

Identi�ication of astrocytes
Glial �ibrillary acidic protein (GFAP) is a consensually accepted speci�ic marker of astocytes. In the present study, the immuno�luorescence technique was used to identify 
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astrocytes by detecting GFAP expression in cultured cells. As shown in Fig. 1 , the cells were uniformly labeled by green �luorescence, which indicated that the cells utilized in the present study were astrocytes.
Levels of IL-1β, IL-6 and TNF-α by ELISA
As shown in Fig. 2 , the levels of IL-1β, IL-6 and TNF-α in the cell culture supernant were markedly increased after stimulation by LPS compared to PBS control group. Ketamine (100 and 1000 µM) pretreatment for 15 min signi�icantly inhibited the production of IL-1β, IL-6 and TNF-α from astrocytes stimulated by LPS (1µg ml -1 ). In contrast, ketamine at the concentration of 10 µM did not appreciably affect release of these proin�lammatory cytokines from LPS-activated astrocytes. Fig. 2 . Effects of ketamine on proin�lammatory cytokines production in LPS activated astrocytes. Astrocytes were treated with ketamine (10, 100, and 1000µM) for 15 minutes, followed by the addition of LPS (1µg.ml −1 ) for 24 hours. The PBS group added an isovolumetric PBS buffer for 24 hours. Cell-free supernatants were assayed for IL-1β (A), IL-6 (B) and TNF-α (C) levels by ELISA. Data are presented as the Mean±SD (n=3). **P<0.01, compared to PBS group; ## P<0.01, compared to LPS group. ). The cells were hypertrophied and showed thicker GFAP-positive staining. C: Astrocytes treated with ketamine (1000µM) followed by treatment with LPS (1.0 µg ml -1 ). After pretreatment with ketamine, the activation of astrocytes by LPS was markedly attenuated.
Effect of ketamine on GFAP expression in astrocytes stimulated by LPS
The expression intensity of GFAP in astocytes was examined by immuno�luorescence. After LPS stimulation, the size of astrocytes was increased and the expression of GFAP was markedly enhanced. Ketamine signi�icantly inhibited increased cell body volume and elevated expression of GFAP in astrocytes challenged by LPS (Fig. 3) .
Western Blot Analysis for TLR4
Subsequently, in order to clarify the mechanism through which ketamine inhibits astrocyte activation, we further investigated the expression of TLR4 in astrocytes by western blot analysis. In this study TLR4 expression in astrocytes was markedly upregulated by LPS stimulation. Ketamine at the concentration of 100 and 1000 µM signi�icantly suppressed TLR4 expression challenged by LPS. In contrast, 10 µM keatmine did not reduce LPS induced expression of TLR4 (Fig. 4) .
Western Blot Analysis for NF-κB
Both total and phosphorylated NF-κB p-65 in astrocytes were also detected by western blot analysis. As shown in Fig. 5 , there was no signi�icant difference among all the experiment groups for total NF-κB p-65 expression in astrocytes. However, the phosphorylated NF-κB p-65 in astrocytes was markedly upregulated by LPS stimulation. Ketamine at the concentration of 100 and 1000 µM signi�icantly attenuated LPS induced phosphorylation of NF-κB p-65 in astrocytes. In contrast, 10 µM ketamine did not inhibit the expression of phosphorylated NF-κB p-65 challenged by LPS. (Fig. 6)   Fig. 4 . TLR4 expression in astrocytes after LPS treatment with or without the presence of ketamine. LPS signi�icantly enhanced TLR4 expression. Ketamine at a concentration of 100 and 1000 µM suppressed TLR4 expression after LPS challenge. At 10 µM ketamine did not reduce the expression of TLR4. **p<0.01, vs PBS group; # p<0.05, vs LPS group. 
Discussion
In this study we investigated the effect of ketamine on in�lammatory responses of primary culture of rat astrocytes stimulated with LPS. We found that ketamine blunted the activation of astrocytes by LPS and reduced LPS-stimulated production of IL-1β, IL-6 and TNF-α in astrocytes. Ketamine was also found to inhibit LPS-induced TLR4 expression and NF-κB activation in astrocytes. Signi�icant effects on astrocytes were observed at ketamine concentrations of 100 and 1000 µM in media supplemented with serum. A previous study demonstrated that plasma levels of ketamine varied from 9000 to 25800 ng/ml or 37.8-108.4 µM in patients 1minute after intravenous ketamine injection at a dose of 2.0-2.2 mg/ kg [18] . Thus, a ketamine concentration of 100 µM is observed in vivo. Our results suggest that clinically relevant or higher concentrations of ketamine may modulate some of the in�lammatory responses of astrocytes stimulated by LPS in vitro by suppressing TLR4/NF-κB pathway, assuming that protein binding is comparable in the serum-supplemented media and plasma.
Astrocytes, the most abundant glial cell type in central nervous system, provide metabolic and trophic support for neurons and modulate synaptic transmission and plasticity [19, 20] . They have a major role in regulation of the extracellular ionic environment and protect neurons from oxidative stress and excitotoxicity [21, 22] . In some instance, excessive activation of astrocytes and sustained production of proin�lammatory cytokines will lead to acute or chronic brain disorders [23] . Therefore, the regulation of astrocyte in�lammatory response may be important in the maintainance of normal central nervous system function.
Astrocytes become activated in response to various stimuli, from subtle changes in their microenvironment to massive tissue damage. This process, known as reactive astrogliosis, far from being an all-or-none event, is a �inely graded and non-homogeneous response that varies according to the type, severity, time and duration of the insult [24] . Histopathologically, reactive astrocytes undergo hypertrophy and increase the expression of GFAP [24] . Reactive astrocytes release a wide array of mediators, including pro-in�lammatory cytokines [24] . The present study shows that ketamine markedly inhibited hypertrophy of astrocytes and enhanced expression of GFAP in astrocytes induced by LPS. In addition, the production of IL-1β, IL-6 and TNF-α in astrocytes stimulated by LPS was also signi�icantly suppressed. The observations suggest that ketamine attenuates the activation and the excessive in�lammatory responses of astrocytes by LPS and that ketamine thus protects against in�lammation of the central nervous system. This anti-in�lammatory action of ketamine found in our study was consistent with the previous reports [10] .
Although the present and previous studies have shown the antiin�lammatory actions of ketamine on astrocytes challenged by LPS [10] , the exact mechanisms responsible for these actions are incompletely understood. Toll-like receptor 4 (TLR4) is a transmembrane receptor protein with extracellular leucine-rich repeated domains and a cytoplasmic signaling domain. TLR4 is involved in immune responses, especially in the activation of innate immunity, but it also triggers adaptative immunity [25] [26] [27] . LPS, a major component of the outer membrane of gram-negative bacteria, is a well known exogenous ligand for TLR4 [28] . LPS binds to lipopolycaccharide-binding protein and be transferred to CD14 [29, 30] . TLR4 is a CD-14 associated transmembrane signal transducer, which is necessary for the LPS-induced cellular response [31] [32] [33] . Recent studies have suggestted that the association of TLR4 with myeloid differentiation factor 88(MyD88) may induce the activation of IL-1R associated kinase and TNF receptor-associated factor [34] , which triggers in�lammatory cascade reactions. Nuclear factor kappa B (NF-κB) is an important nuclear transcription factor. NF-κB heterodimer consists of p50 and p65 (Rel A) subunits. It plays a pivotal role in immune and in�lammatory responses through the regulation of the expression of several proteins, including pro-in�lammatory cytokines, chemokines, and adhesion molecules. Uncontrolled activation of the NF-κB pathway is involved in the pathogenesis of many acute and chronic in�lammatory diseases [35] . In its inactive state, the NF-κB dimer is present in the cytosol, where it is bound to an inhibitory protein, I-κB. Activation of NF-κB by several stimuli, including LPS, induces the release and degradation of the inhibitory protein I-κB from the dimeric complex, followed by phosphorylation of NF-κB p65 and translocation to the nucleus [36] . In the nucleus, NF-κB is bound to corresponding sites to regulate transcription of many proin�lammatory genes [37, 38] .
TLR4-mediated signaling pathways mainly stimulate the activation of nuclear factor kappa B (NF-κB) [39] . This important nuclear transcription factor regulates many proin�lammatory genes, such as cytokines, chemokines, cyclooxygenase-2 (COX-2), matrix metalloproteinase-9 (MMP-9), and in�lammatory mediators involved in the pathogenesis of many central nervous system (CNS) diseases [37, 38] . TLR4-mediated NF-κB signaling plays a vital role in the initiation of neuropathic pain, cerebral ischemic injury, traumatic brain injury and other in�lammatory or autoimmune CNS diseases [40, 41] .
In the present study, we used LPS to induce an in�lammatory response of astrocytes. The results showed that LPS elevated the expression of TLR4 and activated NF-κB in astrocytes, a �inding in agreement with previous studies [42, 43] . Here, we also show that ketamine treatment could reduce LPS-induced TLR4 expression and NF-κB phosphorylation in astrocytes. Since TLR4 is an essential upstream sensor for LPS and may mediate the NF-κB activation, and NF-κB activation can increase the production of IL-1β, IL-6 and TNF-α, it is possible that ketamine decreases the production of proin�lammatory cytokines IL-1β, IL-6 and TNF-α by suppressing the activation of TLR4/NF-κB signaling in LPS challenged astrocytes. Our results suggest that suppression of TLR4/NF-κB signaling may be the probable mechanism through which ketamine attenuated LPS induced in�lammatory responses in astrocytes.
In conclusion, our �indings indicate that ketamine blunts the activation of astrocytes by LPS and reduces the production of proin�lammatory cytokines IL-1β, IL-6 and TNF-α by interfering with TLR4/NF-κB signaling. These properties of ketamine may contribute to its anti-in�lammatory effects in the central nervous system.
